Biotech Values

[mcbio]

Re: SNY-authorized generic

I have read on various boards that a generic could capture up to 80% of the Lovenox market. Why wouldn't Sanofit automatically launch an authorized generic if that is likely to happen?

Because they would cannibalize a ton of the sales of their branded Lovenox. I.e., why would someone buy their pricier branded Lovenox when the same company offers the same exact drug in generic form? By not offering a generic, they would hope that there would be lingering doubt perhaps as to the equivalency of the generic versions of Lovenox which, if true, would allow their branded version to maintain more of its market share.